Lawrenceburg, IN, United States of America

Gregory Conn

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 83(Granted Patents)


Location History:

  • Cincinnati, OH (US) (2014)
  • Lawrenceburg, IN (US) (2017 - 2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gregory Conn: Innovator in Immune Response Technologies

Introduction

Gregory Conn is a notable inventor based in Lawrenceburg, IN (US). He has made significant contributions to the field of biotechnology, particularly in the area of immune response activation. With a total of 4 patents to his name, Conn's work is paving the way for advancements in medical treatments.

Latest Patents

Conn's latest patents focus on the stimulation of an immune response through the use of enantiomers of cationic lipids. One of his key inventions is a composition and method for activating immune cells ex-vivo or inducing an immune response in a subject. This composition includes at least one chiral cationic lipid, which is a nonsteroidal cationic lipid characterized by a specific structural formula. The chiral cationic lipid features a quaternary ammonium group and a spacer that can be a hydrocarbon chain, an ester, a ketone, or a peptide. Additionally, the structure includes a chiral carbon and various fatty acid combinations, enhancing its potential for therapeutic applications.

Career Highlights

Gregory Conn is currently associated with PDS Biotechnology Corporation, where he continues to innovate in the field of biotechnology. His work is instrumental in developing new methods for immune response activation, which could lead to breakthroughs in treating various diseases.

Collaborations

Conn collaborates with esteemed colleagues such as Frank Bedu-Addo and Leaf Huang. Their combined expertise contributes to the advancement of research and development in immune response technologies.

Conclusion

Gregory Conn's innovative work in the field of biotechnology, particularly in immune response activation, showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving health outcomes through cutting-edge research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…